Russell Investments Group’s Ariad Pharmaceuticals Inc ARIA Stock Holding History

Russell Investments Group’s Portfolio ARIA Stock Details ARIA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-60,142	Closed	-$746K	–	3193
2016 Q4	$746K	Buy	+60,142	New	+$724K	﹤0.01%	2322

Other funds holding ARIA

FPF

FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return

Russell Investments Group's ARIA Position: Q1 2017 in Review

Russell Investments Group sold out of Ariad Pharmaceuticals Inc (ARIA) in Q1 2017, closing a stake of 60,142 shares — an estimated $746K sold.

Russell Investments Group first reported a position in ARIA in Q4 2016 and held it in 1 quarter. The position peaked at $746K in Q4 2016. 1 fund tracked by Wall St. Rank holds ARIA as of Q1 2017.

Russell Investments Group reported no remaining Ariad Pharmaceuticals Inc position as of Q1 2017 after selling out during the quarter.
Russell Investments Group sold 60,142 Ariad Pharmaceuticals Inc shares in Q1 2017, an estimated $746K.
Russell Investments Group first reported a position in Ariad Pharmaceuticals Inc in Q4 2016 and held it in 1 quarter.
Russell Investments Group's Ariad Pharmaceuticals Inc position peaked at $746K in Q4 2016.
1 fund tracked by Wall St. Rank held Ariad Pharmaceuticals Inc as of Q1 2017.

Based on Russell Investments Group's 13F filing for Q1 2017, filed 26 Apr 2017.